Clinical Residencies and Fellowships

Medicine and Dentistry

1. Patient 100%
2. Breast Cancer 44%
3. Neoplasm 42%
4. Malignant Neoplasm 32%
5. Therapeutic Procedure 32%
6. Surgery 28%
7. Disease 23%
8. Cancer 21%
9. Inpatient 20%
10. Lung Cancer 20%
11. Diagnosis 19%
12. Radiation Therapy 18%
13. Overall Survival 17%
14. Breast 15%
15. Consensus 15%
16. Analysis 14%
17. Oncologist 14%
18. Woman 14%
19. Recurrent Disease 12%
20. Association 12%
21. Non Small Cell Lung Cancer 11%
22. Symptomatic Treatment 11%
23. Oncology 11%
24. Pathologist 11%
25. Combination Therapy 10%
26. Head and Neck Cancer 10%
27. Lung 10%
28. Survival 10%
29. Physician 10%
30. Ovarian Cancer 10%
31. Retroperitoneal Lymph Node Dissection 10%
32. Adenocarcinoma 9%
33. Lesion 9%
34. Age 8%
35. Brain Metastasis 8%
36. Mastectomy 8%
37. Metastatic Carcinoma 8%
38. Chemotherapy 7%
39. Nodular Melanoma 7%
40. Medicare 7%
41. Lung Adenocarcinoma 7%
42. Clear Cell Renal Cell Carcinoma 7%
43. Specimen 6%
44. Neoadjuvant Therapy 6%
45. Intraductal Carcinoma 6%
46. Stereotactic Radiosurgery 6%
47. Biopsy 6%
48. Evaluation Study 6%
49. Hazard Ratio 6%
50. Awareness 6%
51. Squamous Cell Carcinoma 6%
52. Neoadjuvant Chemotherapy 6%
53. Experience 5%
54. Sentinel Node 5%
55. Prognosis 5%
56. Follow up 5%
57. Pancreas Adenocarcinoma 5%
58. Pharmacist 5%
59. Surgeon 5%
60. Head and Neck Squamous Cell Carcinoma 5%
61. Lymph Node 5%
62. Development 5%
63. Toxicity 5%
64. Surveillance 5%
65. Cancer Therapy 5%
66. Lung Tumor 5%
67. Screening 5%
68. Magnetic Resonance Imaging 5%